Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

IBUPROFEN ORAL SUSPENS

Active
SPE2DP-26-T-4225Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

BLDG 63 EAST CAMP DRIVE, SEA GIRT, NJ, 08750-0000, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4225.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
JAMES FOGGIE
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
IBUPROFEN ORAL SUSPENSION
IBUPROFEN ORAL SUSPENSION,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
ORAL DOSE FORM : "BERRY FLAVOR" SUSPENSION, ORAL (FINAL DOSE FORM)
STRENGTH : 100 MG/5 ML. UNIT OF ISSUE IS A BOTTLE CONTAINING 120 ML (OR
4 FLUID OUNCES).. TOTAL SHELF LIFE IS 24 MONTHS.. THERE SHALL BE A
MINIMUM OF 21 MONTHS OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT BY
THE FIRST GOVERNMENT ACTIVITY.. STORE AT 20° TO 25°C (68° TO 77°F) [SEE
USP CONTROLLED ROOM TEMPERATURE]. DO NOT FREEZE AND SHAKE WELL BEFORE
USING.. LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING
STANDARD NO. 1A DATED 4 FEBRUARY 2013. 8/15/2016.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT:
SPE2DP-26-T-4225
SECTION B
https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
PADAGIS US LLC 9MGE4 P/N NDC45802-0952-26
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017564602 0001 BT 5.000
NSN/MATERIAL:6505013165049
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-316-5049 Quantity: 5 BT Purchase Request: 7017564602QTY: 5 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
Packaging and Labeling ComplianceAll packaging and accompanying documents must be clearly labeled with contract identification numbers from Blocks 1 and 2 to comply with Department of Defense traceability and receipt standards. This subcontract, issued by the Defense Logistics Agency under the NAICS code 325412, ensures end-to-end accountability through precise labeling practices, critical for operational readiness and logistical accuracy. The requirement applies to all delivered items and their documentation, regardless of location, and is tied to the contract reference SPE2DX25D9900 with delivery identifier SPE2DP26F6915. The obligation is non-negotiable and fundamental to successful acceptance by DOD receiving activities.
Defense Logistics Agency

POSTED

about 18 hours ago

DEADLINE

N/A
View Details
NAICS: 325412
New
DIBBS
Supply of Omeprazole Extended-Release Capsules (3,000 Units)The contract requires the manufacture, packaging, and delivery of 3,000 units of Omeprazole Extended-Release Capsules in full compliance with FDA current Good Manufacturing Practices and military labeling standards. The product must be delivered to Kunsan Air Base in South Korea, ensuring adherence to stringent regulatory and operational requirements for pharmaceuticals supplied to U.S. military facilities. The work is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing, and is administered by the Defense Logistics Agency under the Department of Defense. Though solicitation and set-aside details are not provided, the contract is officially posted as of July 21, 2026, with a unique contract identifier linking to the DIBBS system for tracking and fulfillment purposes.
Defense Logistics Agency

POSTED

about 18 hours ago

DEADLINE

N/A
View Details
NAICS: 325412
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride 0.9% Injection, USP, in 250 mL bags, is being procured under contract SPE2DP-26-T-4215 with a requirement for two packaging groups, each containing 24 bags, for a total of 48 units. The product must comply with the DLA Master List of Technical and Quality Requirements, including Medical Marking Standard No. 1, which replaces all prior references to MIL-STD-129, and all packaging must be commercial grade, sealed, and designed to protect against damage during transport. Each unit must be packed in suitable shipping containers that ensure safe delivery via common carrier to the designated destination at the lowest possible freight cost. The item is regulated by the FDA, and procurement requires confirmation through EBS referral to the product specialist, including manufacturer and part number details. The product has a fixed 24-month shelf life with no extensions allowed, and must be stored at room temperature (25°C), with brief exposure to temperatures up to 40°C permitted without degradation. Approved manufacturers include B. Braun Medical Inc., ICU Medical, Inc., Cardinal Health 200, LLC, Owens & Minor Distribution Inc., and Trillamed LLC, each with specified NDC and part numbers. Delivery is required FOB destination within 20 days, with no tolerance for quantity variance. Inspection and acceptance occur at the delivery point, and the item is identified by NSN 6505-01-331-8945 under a federal solicitation issued by the Department of Defense’s Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PENTOBARBITAL SODIUPentobarbital Sodium Injection, Veterinary, is a Schedule II controlled substance with high abuse potential, manufactured as a 250 mL vial containing six grains of sodium pentobarbital for euthanasia purposes. The product is regulated by the FDA and subject to stringent federal controls, requiring storage in a vault at room temperature due to its classification as a DEA C-II drug. It must be labeled and packaged in accordance with the latest Medical Marking Standard No. 1 and DLA Packaging Requirements, with no tolerance for quantity variance—exactly two units are contracted for delivery within 89 days FOB destination, inspected and accepted at the delivery point. The item carries a non-extendable 24-month shelf life and must comply with OSHA’s Hazard Communication Standard, including submission of approved Safety Data Sheets and GHS-compliant labels prior to contract award. Suppliers are required to ensure employee training on hazardous communication protocols under 29 C.F.R. 1910.1200 and must remove all government identification from non-accepted items. This procurement is governed under solicitation SPE2DP-26-T-4219, with primary point of contact at the Department of Defense’s Medical Supply Chain, and delivery addressed to APO 96260-5479.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
MULTIPLE
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PERMETHRIN CREAM RINSEPermethrin Cream Rinse is a 1% w/v topical pharmaceutical product supplied in plastic squeeze bottles containing 2 fluid ounces, each accompanied by a comb for application. The item is regulated by the FDA and must be received with a minimum of 21 months of remaining shelf life from the date of delivery, with a total shelf life of 24 months. Packaging must comply with commercial standards and medical marking standard No. 1, superseding all prior references to MIL-STD-129, ensuring protection against damage and safe transport via common carriers. Each unit must be sealed in an appropriate container and packed in suitable shipping containers to guarantee secure delivery to the designated FPO address. The product is classified as a hazardous material, requiring submission of current Safety Data Sheets (SDS) consistent with OSHA’s revised Hazard Communication Standard, which replaced MSDS requirements as of June 1, 2015. SDS must be provided to the contracting officer for approval prior to award and must accompany each shipment. Labels must conform to GHS and relevant federal regulations under 29 C.F.R. 1910.1200. Packaging must meet 49 CFR and ICAO standards for hazardous materials transport. The item is identified by NSN 6505-01-256-4972, with a purchase request of 2 units and a delivery deadline of 20 days after order award. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with applicable references RA001, RP001, and RQ001, and the procurement is issued under solicitation SPE2DP-26-T-4223 by the Department of Defense’s Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection 0.9% in 100 mL fill plastic containers, packaged in lots of 64 units per purchase group, is being procured under contract SPE2DP-26-T-4218 with a delivery requirement of 20 days FOB destination. The item is manufactured by B. Braun Medical Inc. with NDC 00264-1800-32 and part number S8004-5264, and is identified by NSN 6505-01-330-8924. The product has a non-extendable shelf life of 15 months and must be stored at room temperature, avoiding excessive heat. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must include the NSN, manufacturer, Cage code, date of manufacture, expiration or retest date, contract number, and lot number. Each unit must be sealed in a protective container, and shipments must use commercial exterior packaging suitable for safe transport by common carrier at the lowest cost. The contract specifies zero variance in quantity and requires inspection and acceptance at the destination. This is a regulated medical product under FDA oversight, and the contracting official must submit a referral in EBS for confirmation prior to award. The solicitation was posted on July 21, 2026, with a response deadline of July 27, 2026, and performance is directed to Fort Campbell, 42223-5000.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
TEST STRIPS AND COLORThe contract specifies the procurement of test strips and color charts for urinalysis, capable of detecting bilirubin, blood, glucose, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen in urine, with a unit of issue being one bottle containing 100 strips. The item is identified by NSN 6550-01-221-5400 and is subject to strict technical and quality requirements referenced from the DLA Master List of Technical and Quality Requirements. Packaging must comply with commercial standards and the Medical Marking Standard No. 1, superseding MIL-STD-129, ensuring protected, sealed unit containers and shipping containers suitable for safe delivery via common carriers at the lowest cost. All labeling must include the date of manufacture, expiration or retest date, contract number, and lot number in accordance with MMS1C. The product has a non-extendable shelf life of 18 months, and no more than two months may have elapsed from the date of manufacture to the date of delivery to the government. The solicitation, issued under SPE2DS-26-T-256B, requires responses by July 27, 2026, with delivery expected within 20 days after award, and is managed by the Department of Defense through the Medical Supply Chain MD SURG FSF office with Mary-Kathryn Donahue as the point of contact.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ALBUTEROL SULFATE INHA
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
BISMUTH SUBSALICYLATEBismuth subsalicylate tablets are being procured under a military contract with each tablet containing 262 mg of active ingredient and 140 mg of calcium, formulated as sugar-free oral tablets. The unit of issue is a single package containing 48 individually sealed tablets, with a total shelf life of 36 months and a mandatory minimum of 31 months remaining at the time of receipt by the first government activity. Packaging must comply with commercial standards and the Medical Marking Standard No. 1A dated February 4, 2013, ensuring product integrity and proper identification. Containers must protect against damage and breakage, and shipping containers must be suitable for safe delivery via common carrier at the lowest cost to the designated destination. The product is subject to strict temperature controls, avoiding exposure above 104°F or 40°C. The NSN is 6505012448010, with a procurement quantity of one package, delivery required within 20 days FOB destination, and no variance allowed in quantity. Inspection and acceptance occur at the destination. The contract is issued under Solicitation SPE2DP-26-T-4214, with a response deadline of July 27, 2026, and performance will be delivered to Fort Campbell, Kentucky. The supplier must be registered under either P/N NDC01490-0326-42 or NDC37000-0477-10, and all labeling, marking, and packaging must adhere to applicable DLA and DoD standards, including compliance with the DLA Master List of Technical and Quality Requirements incorporated by reference.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
VECURONIUM BROMIDE FOR
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
BUPIVACAINE AND EPINEPThe contract specifies the procurement of bupivacaine and epinephrine injection in 1.8 mL cartridges containing 0.500 percent w/v bupivacaine HCl and 0.005 mg epinephrine per mL (1:200,000), packaged in units of 50 cartridges per carry case (CN). The product must be stored at controlled room temperature between 15 and 30 degrees Celsius with a shelf life of 18 months, ensuring at least 15 months of shelf life remains upon delivery to the first government activity. Packaging and labeling must comply fully with Medical Marking Standard No. 1, superseding MIL-STD-129, and all containers must be sealed and designed to prevent damage during transit. The material is subject to DLA Packaging Requirements and must be shipped using the fastest traceable means, prohibiting parcel post. Hazardous material regulations under Fed-STD-313 apply, requiring compliance with ASTM D3951 unless superseded by higher-priority DLA technical requirements. Mercury and mercury-containing compounds are strictly prohibited unless explicitly exempted for specific functional components. Delivery is FOB destination with zero quantity variance allowed, and the shipment must reach the specified FPO address within 20 days of contract award. The sole point of contact for inquiries is Nicholas Quigley of the Department of Defense’s Medical Supply Chain, and the procurement is governed under solicitation SPE2DP-26-T-4221 with an original required delivery date of July 23, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 423450
New
DIBBS
LIDOCAINE HYDROCHLOLidocaine Hydrochloride and Epinephrine, USP, is a parenteral injectable pharmaceutical product containing a 2 percent concentration of lidocaine hydrochloride and a 1:50,000 dilution of epinephrine bitartrate, supplied in 1.7 mL single-dose cartridges. The unit of issue is a package of 50 cartridges, each contained within cardboard boxes featuring five blisters of ten cartridges each. The product must be stored at controlled room temperature below 25°C (77°F), protected from light, and must not be frozen. It is regulated by the FDA and requires a prescription. The item has a non-extendable shelf life of 18 months and must be marked in full compliance with Medical Marking Standard No. 1, superseding all prior references to MIL-STD-129. Packaging and shipping must meet commercial standards, with each unit sealed and protected in suitable containers to ensure safe transport via common carrier, and all exterior containers must meet federal logistics requirements. The procurement is issued under contract SPE2DP-26-T-4213 with a solicitation posted on July 21, 2026, and responses due by July 27, 2026. The quantity required is one unit of issue (50 cartridges), with delivery required within five days of award to the destination at Joint Base Elmendorf-Richardson, Alaska. Delivery is FOB destination and subject to zero variance in quantity. Inspection and acceptance occur upon delivery. The item is classified under NSN 6505-01-576-2767, with procurement reference PR 7017548713. All technical and quality requirements referenced in the DLA Master List are incorporated by reference, and the product must be sourced from approved manufacturers including Dentsply Sirona Inc. with NDC 66312-0181-16. Government use requires adherence to all applicable defense logistics standards, including transport protocols and marking instructions, with a designated point of contact and official delivery address provided for coordination.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
TETRACAINE HYDROCHL
Medicinal and Botanical Manufacturing

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
PSYLLIUM HYDROPHILIC MThe contract is for Psyllium Hydrophilic Mucilloid in sugar orange flavor, supplied in 12 gm packets, with each packet containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per box. The item is regulated by the FDA and must be procured with the specified manufacturer part number NDC37000-0740-87 from The Procter & Gamble Distributing LLC. It carries a non-extendable 24-month shelf life under Type I (Code M) requirements and must be packaged and marked in strict accordance with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet DLA requirements, including commercial-grade sealed unit containers and shipping containers that ensure safe delivery at the lowest possible rate. The unit of issue is a package of 30s, with a total quantity of 4 packages required. Delivery is FOB destination within 20 days, with zero variance permitted, and inspection and acceptance occur at the delivery point. The shipment is designated for a military vessel, with specific transportation protocols requiring the use of traceable methods and prohibiting parcel post. All labeling, packing, and marking must comply with applicable DLA standards, and bidders must clearly state the source and part number. The contract is issued under solicitation SPE2DP-26-T-4220 with an original delivery deadline of July 23, 2026, and is managed by the Department of Defense’s Medical Supply Chain PHARM FSA.
Medicinal and Botanical Manufacturing

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 456199
New
DIBBS
SODIUM CHLORIDE IRR
All Other Health and Personal Care Retailers

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection, USP, in 0.9% 1000ml IV plastic bags, latex free, is being procured under solicitation SPE2DP-26-T-4133 by the Department of Defense through the Medical Supply Chain Pharm FSA. The item is identified by NSN 6505-01-330-6269 and is to be delivered in packages of 12 units per package, with a total quantity of 19 packages ordered across three line items. Delivery is required within 20 days after the date of order, with FOB Destination terms, and inspection and acceptance occur at the point of delivery. The product is regulated by the FDA and must be stored at 20° to 25°C (68° to 77°F), avoiding excessive heat, freezing, and incompatible materials. Packaging and marking must comply with Medical Marking Standard No. 1 (MMS No. 1), which supersedes MIL-STD-129, and packaging data must adhere to MIL-STD-2073-1E. Commercial packaging standards apply, with each unit sealed in a suitable container to prevent damage and shipped in commercial exterior containers designed for safe and economical transport. The product carries a non-extendable shelf life of 30 months as a TYPE I (CODE P) item. Manufacturers include B. Braun Medical Inc. and ICU Medical Sales, Inc., with approved part numbers listed. All offers must be submitted via the DLA Internet Bid Board System (DIBBS) by the deadline of July 21, 2026. The contract incorporates multiple FAR clauses, including those related to system for award management maintenance, small business representation, combating trafficking in persons, employment eligibility verification, sustainable products, hazardous material identification, safeguarding information systems, and changes under fixed-price contract type, all under deviation 2026-00038. NIST SP 800-171 DOD assessment requirements apply, and contractors must maintain active SAM registration and WAWF access for invoicing and receiving reports. Payment is processed electronically through WAWF, requiring compliance with DFARS Appendix F and FAR 52.216-7. Hazardous material labeling must conform to 29 CFR 1910.1200 and FDA standards, with Material Safety Data Sheets submitted alongside labels. Contractors retain
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 18 hours ago

DEADLINE

in 2 days
View Details
NAICS: 325411
New
DIBBS
VERAPAMIL HYDROCHLORIDVerapamil hydrochloride injection is a 5 mg per 2 mL (2.5 mg/mL) preservative-free, single-dose solution supplied in 2 mL glass flip-top vials, with a package quantity of 25 vials per unit. The product is intended solely for intravenous use and must be protected from light during storage and handling. It should be stored at a controlled room temperature of 20 to 25°C (68 to 77°F) in accordance with USP standards. The item has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The NSN is 6505-01-738-0226, and the purchase request number is 7017548722 with a delivery requirement of five days after order award. The contract is issued under solicitation number SPE2DP-26-T-4217, posted on July 21, 2026, with a response deadline of July 27, 2026. The NAICS code is 325411, and the contracting agency is the Department of Defense through the Medical Supply Chain Pharmaceutical FSA. Delivery is to Joint Base Elmendorf-Richardson in Alaska, 99506-4400. The contract incorporates technical and quality requirements from the DLA Master List and applies DLA packaging standards. Covered defense information may apply, and federal regulations require removal of government identification from non-accepted supplies. Primary point of contact is Daniel Porter, reachable by phone or email as listed.
Medicinal and Botanical Manufacturing

POSTED

about 18 hours ago

DEADLINE

in 5 days
View Details